# Minocycline Pharmacokinetics (ACUMIN)

> **NCT03369951** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 58 (actual)

## Conditions studied

- Bacterial Infection

## Interventions

- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT03369951
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-28
- **Primary completion:** 2019-07-20
- **Final completion:** 2019-07-20
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03369951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03369951, "Minocycline Pharmacokinetics (ACUMIN)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03369951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*